Skip to main content

KBC Group NV

Position in CRSP — CRISPR Therapeutics AG

CIK 1411133 Brussels, C9

Position in CRSP

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$6,372,835
+$814,424 QoQ
Shares Held
116,847
0.0% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#58
of 505 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

KBC Group NV holds $308,329,117 across 107 Biotechnology names. CRSP ranks #8 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 CRSP
CRISPR Therapeutics AG
This page
116,847 $6,372,835

All Filings in CRSP

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,372,835 116,847
2026-03-31 $5,558,411 116,847
2025-12-31 $149,454 2,850
2025-09-30 $144,137 2,224
2025-06-30 $108,175 2,224
2025-03-31 $127,612 3,750
2024-12-31 $2,381,831 60,514
2024-09-30 $132,389 2,818
2024-06-30 $105,751 1,958
2024-03-31 $109,533 1,607
2023-12-31 $100,598 1,607
2023-09-30 $72,941 1,607
2021-09-30 $67,158 600
2021-06-30 $97,134 600
2021-03-31 $73,110 600
2020-12-31 $91,866 600
2020-09-30 $100,368 1,200
2020-06-30 $88,188 1,200
2020-03-31 $50,892 1,200